Clotbuster Concentric Medical files for $69M IPO
Mountain View, Calif.-based Concentric Medical, which makes and markets devices for removing dangerous blood clots from the brains of stroke patients, filed to raise up to $69 million in an initial offering. See our story in today’s daily briefing at VentureBeat Life Sciences.
Next Story: Stem-cell “brain drain” or “brain gain”?
Previous Story: Life sciences briefing: Friday, Aug. 17, 2007
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.